Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

HIV Diagnostics Market - Antibody Test Segment to hold largest market share till 2023

Global Market Insights,Inc.
Posted on: 31 Aug 17
HIV Diagnostics Market - Antibody Test Segment to hold largest market share till 2023 North America HIV Diagnostics Market is poised to grow at a moderate CAGR in coming years propelled by rapid adoption of technologically advanced diagnostic solution service providers & increasing demand for point of care tests.

PR Newswire

OCEAN VIEW, Del., Aug. 31, 2017

OCEAN VIEW, Del., Aug. 31, 2017 /PRNewswire-iReach/ -- The Industry growth report "HIV Diagnostics Market  By Product [Antibody Tests (HIV-1 Screening, ELISA/EIA, Home Access Dried Blood Spot, Rapid Test, HIV-1 Confirmatory Steps, Western Blot, Indirect Immunoflorescent Antibody Assay (IIFA), Line Immunoassay , RadioImmuno Precipitation Assay (RIPA), HIV-2 & Group O Test, Blood Antibody, Dried Blood Spot), Viral Identification Assay (p24 Antigen, Qualitative PCR, Viral Culture), CD4, Viral Load, Early Infant Diagnosis], Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, Japan, China, South Africa, Brazil), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023" by Global Market Insights, Inc. forecast HIV Diagnostics Market share is poised to cross $4.9 billion by 2024.

HIV is found to be most common ailment, particularly in resource limited areas due to low health consciousness among the people and successful execution of antiretroviral treatment program. Rising occurrence of HIV has resulted in growing concerns among government to promote investments in events aimed at eradicating burden prices of HIV. Many such events include encouraging people to go for regular check-ups. Multinational healthcare units like UNITAID spread HIV awareness and fund new technologies for treating and annihilating HIV.

Request for a sample of this research report @

Increasing point of care diagnostics sector is projected to favorably affect global HIV diagnostics industry. Different aspects like cost efficacy, toughness, minimal device requirement and quick diagnosis are anticipated to promote HIV point of care diagnostics sector. Technological breakthroughs in biochemical engineering for designing these tests in order to permit consecutive identification and quantification of many targets with use of limited resource settings are projected to propel industry expansion.

To access sample pages or view this report titled, "HIV Diagnostics Market" in detail along with the table of contents:

Global HIV diagnostics industry is segmented into various products like viral load, early infant diagnosis, antibody tests, viral identification assay and CD4.

Antibody tests segment is sub-segmented into western blot tests, HIV-1 screening tests, dried blood spot tests, ELISA (enzyme linked immunosorbent assay) tests, HIV- confirmatory tests, rapid test, western blot tests, line immunoassay, blood anti body tests, RIPA (radio immuno precipitation assay) tests, HIV-2 & group O tests and indirect immunofluorescent antibody assay (IIFA) tests.

This segment is predicted to contribute largely to HIV diagnostics market share during forecast timeline and is projected to surpass $1.6 billion by end of 2023. Extensive use and launching of modern point of care methods intended to surpass the cell distinguishing limitations and offer accurate outcomes will promote the segment expansion.

Viral identification assay segment is sub-segmented into viral culture, p24 antigen and qualitative PCR (polymerase chain reaction). Viral culture assay sub segment projected to touch $530 million by end of 2023 led the segment.

Viral load and CD4 segments are projected to register comparatively high CAGR of 9.91% and 10.2% during forecast timeline owing to increasing industry penetration as well as expansion of point of care diagnostics methods for such tests that would improve marketability in limited resource settings.

Make an inquiry for purchasing this report @

Global HIV diagnostics market is segmented into North America, Asia Pacific, Middle East & Africa, Europe and Latin America.

North America HIV diagnostics market price was evaluated at $947 million for 2015 and it dominated the global industry during the year. Factors like rapid acceptance of technologically modernized diagnostic solutions service providers and growing demand for point of care tests in the region has promoted regional industry expansion.

Asia Pacific HIV diagnostics industry is projected to register CAGR of 10.8% during forecast timeline due to enhancement in healthcare services coupled with rise in levels of HIV consciousness amongst the population of the region. Further, the region possesses large pool of patients suffering from HIV ailment and this is projected to stimulate regional industry growth.

Browse Related Reports:

Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2017-2024

Human Immunodeficiency Virus (HIV)-1 Therapeutics Market share is projected to experience significant growth from 2017 to 2024. Human immunodeficiency virus therapeutics market size should witness tremendous growth, owing to the sprouting incidence of HIV infections.

Artificial Pancreas Device System Market Size 2017-2024

Artificial Pancreas Device System Market share is projected to experience significant growth from 2017 to 2024. Artificial pancreas device system market size should witness significant growth due to increasing number of people suffering from type 1 diabetes.

Browse Latest Research News Here:

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Connect with us: Facebook | Google+ | LinkedIn | Twitter

Media Contact: Arun Hegde, Global Market Insights, Inc., +13028467766,

News distributed by PR Newswire iReach:

SOURCE Global Market Insights, Inc.

PR Newswire

Last updated on: 31/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.